losartan-potassium and Hypopituitarism

losartan-potassium has been researched along with Hypopituitarism* in 5 studies

Reviews

1 review(s) available for losartan-potassium and Hypopituitarism

ArticleYear
[Endocrine diseases and hematologic anomelies].
    Horumon to rinsho. Clinical endocrinology, 1974, Volume: 22, Issue:8

    Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Anemia; Anemia, Hemolytic; Animals; Dwarfism, Pituitary; Endocrine System Diseases; Erythropoiesis; Erythropoietin; Female; Hematologic Diseases; Humans; Hypopituitarism; Male; Mice; Pituitary Diseases; Polycythemia; Rabbits; Thyroid Diseases; Thyroiditis, Autoimmune

1974

Other Studies

4 other study(ies) available for losartan-potassium and Hypopituitarism

ArticleYear
Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism.
    Journal of endocrinological investigation, 2000, Volume: 23, Issue:1

    We studied the effect of treatment with recombinant human GH in an anemic patient with panhypopituitarism in which hemoglobin (Hb) concentration remained as low as 11.0 g/dl in spite of appropriate replacement with thyroid and adrenocortical hormones. Recombinant human GH was subcutaneously and constantly infused for 12 months using a portable syringe pump at a rate of 0.25 U/kg/week. After the treatment with human GH plasma erythropoietin (EPO) levels increased from 12.2 to 25.1 mIU/ml, with a concomitant increase of Hb concentration to 13.6 g/dl. When the administration of human GH was interrupted, both plasma EPO levels and Hb concentrations decreased. There was a close correlation between plasma GH and EPO levels before and during the human GH administration (y=2.444x+1 3.423, r=0.641, p<0.05). Plasma GH levels were well correlated with Hb concentrations before and during human GH administration (y=0.529x+11.313, r=0.690, p<0.01). Plasma IGF4 levels were also correlated with Hb concentrations (y=0.007x+10.874, r=0.832, p<0.001), but not with plasma EPO levels. These findings suggest that GH treatment may be useful in anemic patients with panhypopituitarism.

    Topics: Anemia; Erythropoietin; Female; Hemoglobins; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Middle Aged

2000
Improvement of anemia by recombinant erythropoietin in a patient with postoperative hypopituitarism.
    American journal of hematology, 1994, Volume: 47, Issue:3

    Topics: Adult; Anemia; Erythropoietin; Female; Humans; Hypopituitarism; Postoperative Complications; Recombinant Proteins

1994
Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone.
    Blood, 1972, Volume: 39, Issue:2

    Topics: Anemia, Aplastic; Blood Volume; Bone Marrow; Bone Marrow Cells; Child; Chromium Isotopes; Craniopharyngioma; Dwarfism, Pituitary; Erythropoiesis; Erythropoietin; Growth Hormone; Humans; Hypophysectomy; Hypopituitarism; Iron; Kinetics; Leukocyte Count; Lymphocytes; Male; Radioimmunoassay; Testosterone; Transferrin

1972
Erythropoietin excretion in a hypopituitary patient. Effects of testosterone and vasopressin.
    Archives of internal medicine, 1968, Volume: 122, Issue:3

    Topics: Animals; Chromium Isotopes; Diabetes Insipidus; Erythropoiesis; Erythropoietin; Hemoglobinometry; Humans; Hypopituitarism; Iron; Iron Isotopes; Male; Mice; Middle Aged; Osmotic Fragility; Plasma Volume; Polycythemia; Serum Albumin, Radio-Iodinated; Testosterone; Vasopressins

1968